(Press-News.org) Monroe Carell Jr. Children's Hospital at Vanderbilt has launched a study to determine the impact of a predictive model for identifying pediatric patients at risk for developing blood clots or venous thromboembolisms (VTEs).
The study uses advanced predictive analytics to inform medical teams of patients at risk for blood clots before they happen.
"Hospital-associated blood clots are an increasing cause of morbidity in pediatrics," said the study's principal investigator, Shannon Walker, MD, clinical fellow of Pediatric Hematology-Oncology at Children's Hospital.
While these events are more rare among children than they are among adults, Walker noticed that blood clot development was on the rise.
"The reason children get blood clots is very different from adults," said Walker, who worked with mentors Allison Wheeler, MD, MSCI, assistant professor of Pediatrics and Pathology, Microbiology and Immunology, and C. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program and associate professor of Pediatric Infectious Diseases.
"There was no standardized protocol for preventing clots in pediatric patients. As we noticed that the rate of blood clots was going up and recognized that the adult strategy wasn't going to work for our patients, we wanted to look at each patient's individual risk factors and see how we could focus our attention on targeted blood clot prevention."
The study, set to be published in Pediatrics, describes how the team built and validated a predictive model that can be automated to run within the electronic health record of each patient admitted to the hospital.
The model includes 11 risk factors and was based on an analysis of more than 110,000 admissions to Children's Hospital and has been validated on more than 44,000 separate admissions.
Currently the team is studying using this model along with targeted intervention in the clinical setting in a trial called "Children's Likelihood of Thrombosis," or CLOT.
The prediction model is used in this way: every child admitted to the hospital has a risk score calculated. The patients are randomized, so in half of the patients, elevated scores are reviewed by a hematologist, and then discussed with each patient's medical team and family to determine a personalized prevention plan. All patients, regardless of randomization, continue to receive the current standard of care.
"We are not utilizing a one-size-fits-all plan," Walker said. "This is an extra level of review allowing for a very personalized recommendation for each patient with an elevated score. Each day the score is updated, so as risk factors change, the scores change accordingly.
"We are, in real-time, assessing the use of this model as a clinical support tool. We saw a clinical opportunity of something we could improve and have moved forward with building the model -- to identify high-risk patients and are currently performing the CLOT trial, which will run through the end of the year."
Walker's study was possible with the help of the Advanced Vanderbilt Artificial Intelligence Laboratory, or AVAIL. Only in its second year, the program is leading the way supporting artificial intelligence tools at VUMC through project incubation and curation, including facilitating clinical trials to assess their effectiveness.
"AVAIL served as a catalyst, in this instance by bringing experts in a complex trial development into proximity so that a great synthesis could happen," said Warren Sandberg, MD, PhD, executive sponsor of AVAIL, along with Kevin Johnson, MD.
"What is unique about this particular project is that we were not only able to predict complications but also able to test the model in a rigorous, pragmatic, randomized, controlled trial to see if it benefits patients," said Dan Byrne, senior biostatistician for the project and director of artificial intelligence research for AVAIL.
"The future of this kind of work is unlimited," he said. "We can hopefully use this approach to predict and prevent pressure injuries, sepsis, falls, readmissions or most any complication before they happen. At Vanderbilt, we are raising the bar when it comes to the science of personalized medicine and application of artificial intelligence in medicine in a way that is both ethical and safe."
INFORMATION:
Authors of the paper include Walker, Wheeler, Creech, Byrne, Henry Domenico, MS, and Benjamin French, PhD. Ryan Moore, MS, is the biostatistician for the CLOT trial.
The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.
They found that a lengthy treatment with 1 μM 5-azacitidine, without a significant effect on cell proliferation, sensitized cancer cells to the inhibitory effects of ...
No matter one's age, race, gender, socioeconomic status or political party, COVID-19 has impacted everyone at some level. That impact has been especially palpable for the approximately 1.3 million elderly Americans who reside in the country's 15,600 nursing homes.
Inside these facilities, the forced isolation caused by COVID-19 disrupted daily routines and left many of the residents with higher-then-normal levels of stress, anxiety and depression. Because many of these elderly individuals lack the resources or knowledge to use communications tools such as FaceTime or Zoom, their family and friends had no way to visit them except through a facility window.
What these family members couldn't see as they peered through their loved one's glass frame was the mental ...
CORVALLIS, Ore. - Researchers at Oregon State University have found a key new piece of the puzzle in the quest to use gene therapy to enable people born deaf to hear.
The work centers around a large gene responsible for an inner-ear protein, otoferlin. Mutations in otoferlin are linked to severe congenital hearing loss, a common type of deafness in which patients can hear almost nothing.
"For a long time otoferlin seemed to be a one-trick pony of a protein," said Colin Johnson, associate professor of biochemistry and biophysics in the OSU College of Science. "A lot of genes will find various things to do, but the ...
Rice farmers in Nepal are chronically falling short of their potential productivity. Poor rice yields are persistent across the Terai--a lowland region lying south of the outer foothills of the Himalayas that extends through southern Nepal into northern India--and existing decision support systems are failing to provide the precision required.
To date, farmers in the area have lacked the knowledge and support they need to properly plan nutrient applications for their crops. Current nutrient recommendation systems only provide "blanket" prescriptions that fail ...
VANCOUVER, Wash. - Employer COVID-19 safety measures influenced worker precautions even when they were not on the clock, according to a new study out of Washington State University.
The study found that workplace cultures that adopted COVID-19 prevention measures, such as daily health checks and encouraging sick workers to stay home, resulted in less "sickness presenteeism" or going places when feeling ill. The effect was found both inside and outside of work - meaning fewer employees with COVID-19 symptoms showed up to work and other public places like grocery stores, gyms and restaurants.
The same held true for attitudes toward the COVID-19 prevention measures recommended ...
While some international students come to Canada knowing whether they intend to stay or return home after completing their degrees, the majority decide after they have had a chance to live here for a few years, a new study has found.
"Nearly a quarter of our participants made the decision prior to arriving in Canada," said Elena Neiterman, a lecturer in the School of Public Health and Health Systems at the University of Waterloo. "However, the majority were not certain what their plans for the future were until they had a chance to live here and explore life in Canada."
The students identified several factors shaping their decision to stay or go, including family ties in Canada or abroad, ...
Researchers from Case Western Reserve University have identified a potential new approach to better controlling epileptic seizures.
Lin Mei, professor and chair of the Department of Neurosciences at the Case Western Reserve School of Medicine, who led the new study in mouse models, said the team found a new chemical reaction that could help control epileptic seizures.
Their findings were recently published in The Journal of Clinical Investigation.
Epilepsy is a neurological disorder in which abnormal brain activity causes seizures or periods of unusual behavior, sensations and sometimes loss of awareness.
A human brain contains about 86 billion nerve cells, also known as neurons. Eighty percent ...
Sophia Antipolis, 19 May 2021: Cities harbour a dangerous cocktail of environmental stressors which politicians must tackle to save lives and preserve health. That's the conclusion of a paper published today in European Heart Journal, a journal of the European Society of Cardiology (ESC).1
"By 2050, three in four people will live in cities, where up to 80% of energy is consumed and 70% of greenhouse gases are emitted," said study author Professor Thomas Münzel of the University Medical Centre Mainz, Germany. "There are limited actions that individuals can take to protect themselves from pollutants so politicians and policy makers need to take on this responsibility."
Cardiovascular diseases are the leading cause of mortality in Europe, accounting for 47% and ...
New research published in Anaesthesia (a journal of the Association of Anaesthetists) shows the huge pressure that anaesthesia and critical care staff in the UK have been under throughout the winter wave of COVID-19, as the number of newly admitted infected patients surged and most planned surgeries, including a substantial number of critical cancer operations, were cancelled.
"These findings have important implications for understanding what has happened during the COVID-19 pandemic, planning recovery and building a system that will better respond ...
A general practitioner, wife and mother has recounted her experience with COVID-19 which saw her stay in hospital 150 days and become one of the first patients to be treated with extracorporeal membrane oxygenation (ECMO), special equipment that completely takes over the function of the lungs and is a last resort option.
The self-written case report, which appears in the journal Anaesthesia Reports (a journal of the Association of Anaesthetists) is by Dr Anushua Gupta, who works as a general practitioner in Stockport, Greater Manchester, UK. It is thought to be the first patient-written account of ECMO to treat COVID-19 to appear in the medical literature.
Extracorporeal membrane oxygenation was introduced as ...
